Heart Surgery

Latest Issue of OR Manager
October 2024
Home Surgery/Specialties > Heart Surgery

Machine learning algorithm predicts bleeding during CABG surgery

Editor's Note A machine learning algorithm based on data from the American College of Cardiology’s National Cardiovascular Data Registry accurately identified patients at risk for bleeding during or after coronary artery bypass grafting (CABG) surgery, the August 23 Health IT Analytics reports. Researchers developed the platform using a risk spectrum…

Read More

By: Judy Mathias
August 27, 2019
Share

ASC Manager Issue 2

Healthcare providers have seen a steady stream of inpatient-only procedures migrate to ambulatory surgery centers (ASCs) over the past few years. Medicare is reimbursing an increasing number of procedures performed in the outpatient setting, many of them cardiovascular in nature. This issue of ASC Manager explores the development of a…

Read More

By: Judy Mathias
August 23, 2019
Share

Cardiothoracic surgery patients at high risk for postop opioid dependence

Editor's Note This study finds that the amount of opioids prescribed for patients after cardiothoracic surgery has a direct relationship with the risk for opioid dependence and persistent opioid use several months after surgery. Of nearly 25,000 opioid-naïve Medicare patients analyzed, 15.7% of patients who had lung surgery and 12.5%…

Read More

By: Judy Mathias
August 22, 2019
Share

FDA: Class I recall of Edwards Lifesciences SAPIEN 3 Ultra Delivery System

Editor's Note The Food and Drug Administration on August 22 identified the recall by Edwards Lifesciences of all lots of its SAPIEN 3 Ultra Delivery System as Class I, the most serious. The delivery system is part of the Edwards SAPIEN 3 Transcatheter Heart Valve System. The recall was initiated…

Read More

By: Judy Mathias
August 22, 2019
Share

Sponsored Message

FDA: Class I recall of Ellipse Implantable Cardioverter Defibrillators

Editor's Note The Food & Drug Administration on August 5 identified the recall by Abbott (formerly St Jude Medical Inc) of its Ellipse Implantable Cardioverter Defibrillators as Class I, the most serious. The recall was initiated because electrical failures have been identified that are due to a faulty manufacturing process…

Read More

By: Judy Mathias
August 5, 2019
Share

US News publishes 2019-2020 top hospitals list

Editor's Note The US News & World Report on July 30 released its 2019-2020 Best Hospitals Honor Roll. The top five are: Mayo Clinic, Rochester, Minn Massachusetts General Hospital, Boston Johns Hopkins Hospital, Baltimore Cleveland Clinic New York-Presbyterian Hospital/Columbia and Cornell, New York City. In the specialty rankings: University of…

Read More

By: Judy Mathias
July 30, 2019
Share

Sponsored Message

Study debunks ‘July Effect’ in cardiac surgery

Editor's Note The “July Effect”−the idea that more errors occur in July because of the influx of new interns and residents starting their in-hospital training−does not apply to cardiac surgery, this study finds. For more than 470,000 cardiac procedures analyzed (coronary bypass, aortic valve, mitral valve, thoracic aortic aneurysm), in-hospital…

Read More

By: Judy Mathias
July 25, 2019
Share

FDA: Class I recall of Getinge’s Maquet/Datascope intra-aortic balloon pumps

Editor's Note The Food & Drug Administration on July 23 identified the recall by Getinge of its Maquet/Datascope intra-aortic balloon pumps (IABPs) as Class I, the most serious. Recall of the Cardiosave Hybrid, Cardiosave Rescue, CS300, and CS 100/100i IABPs was initiated because of reports of the IABP batteries failing…

Read More

By: Judy Mathias
July 24, 2019
Share

Effect of incentive spirometer patient reminder after CABG

Editor's Note An incentive spirometer reminder after coronary artery bypass grafting (CABG) improved patient adherence and, in turn, improved the atelectasis severity score and multiple subsequent clinical outcomes, this study finds. In this study of 212 patients who had CABG surgery, 145 were randomized by hourly reminder SpiroTimer “bell on”…

Read More

By: Judy Mathias
July 18, 2019
Share

FDA: Class I recall of Edwards Lifesciences’ IntraClude Intra-Aortic Occlusion Device

Editor's Note The Food and Drug Administration on July 1 identified the recall by Edwards Lifesciences (Irvine, California) of its IntraClude Intra-Aortic Occlusion Device as Class I, the most serious. The recall was initiated because of a risk of balloon rupture during use in patients undergoing cardiopulmonary bypass. The company…

Read More

By: Judy Mathias
July 9, 2019
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat